Multiple myeloma is a complex disease but there is hope for you and your loved ones: we are fully committed to fighting this and all other forms of cancer through the development of cutting-edge, personalised treatments with reduced side effects that can improve quality of life, lessen resistance to therapy and prolong the duration of remission.
Introduction to multiple myeloma
While treatment options have improved over the years, multiple myeloma remains an incredibly complex disease to treat, especially as patients can become resistant to therapy. Sadly, around 50% of newly diagnosed patients do not reach five-year survival. At Janssen, this is something we are working hard to change.
More can be done to address this area of unmet medical need and improve outcomes for these patients. Our goals are:
• Improved treatment efficacy
• Reduce side effects
• Prolonging duration of remission
• Improving quality of life